Table 7 A clinical investigation of the ophthalmic findings affected by the 90-day oral administration of 7%-GNANA, a test substance to the male and female rats (n=10)

Sites	Findings	Groups (mg/kg/day)b)
		G1%			G2			G3			G4
		Male	Female		Male	Female		Male	Female		Male	Female
Left eye	Normal	0 / 5a)	0 / 5a)		0 / 5	0 / 5		0 / 5	0 / 5		0 / 5	0 / 5
Right eye	Normal	0 / 5	0 / 5		0 / 5	0 / 5		0 / 5	0 / 5		0 / 5	0 / 5

^a) Number of animals with the finding / Number of animals examined
%: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day), High-dose group (G4: 5,000 mg/10 mL/day)
The data shown represent mean±S.D. (n=10).